Video: Hapbee Testimonials.
Hapbee is powered by patented ultra-low radio frequency energy (ulRFE®) technology invented by EMulate Therapeutics, Inc., a technology company based in Seattle, WA.
The...
Citius Pharma (CTXR) Video Presentation.
Chairman Leonard Mazur Discusses:
Mino-Lok Treatment for Infected Catheters.
Novellus Stem Cell Treatment for CoronaVirus and Acute Respiratory Distress. (This is not a vaccine folks, it...
Magic Mushroom Compass Pathways (CMPS) IPO Valued at Near $1 Billion.
Shares jumped 71% to $29 in New York after an initial public offering of 7.5 million shares priced at $17 each (Yahoo/Bloomberg)
LIVE QUOTE
‘Magic Mushroom’...
Telehealth: How the Pandemic Forced Mental Health Care to Change for the Better (Vox).
New therapy options were desperately needed before the pandemic
Two facts overshadow all discussions of mental health care in the US.
One is the high and...
Adding Sorrento Therapeutics (SRNE) to CoronaVirus Watch List.
LIVE QUOTE
"Proof of Concept. We take note that Eli Lilly (LLY-Not Rated) reported yesterday'spositive interim results from a placebo-controlled trial of a similar compound...
Mitesco Inc. Initiates “The Good Clinic” Rollout in Minneapolis; Introduces the Founders of “The...
MINNEAPOLIS, MN, Sept. 14, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Mitesco, Inc. (OTCQB: MITI) today announced that The Good Clinic, LLC has filed an application...
Hy-IQ Trademark
REGISTERED 9-15-2020
Aphex BioCleanse Systems (APHX) Plans Filing With Securities & Exchange Commission.
Aphex BioCleanse Systems Appoints Hancock Askew as New PCAOB-Qualified Auditor, Hires Accounting Consultant
PITTSFORD, N.Y., Sept 14, 2020 /PRNewswire/ -- Aphex BioCleanse Systems, Inc. (OTC: SNST) ("Aphex" or "the...
Immunomedics (IMMU) $3.00 to $88, Up 29-fold, Our Second Best Idea Ever.
Interesting Charts From the Day we Discovered it.
Gilead Sciences, Inc. (Nasdaq: GILD) and Immunomedics (Nasdaq: IMMU) announced today that the companies have entered into...
American BriVision’s (ABVC) Clinical Study Sparks Interest From Potential Partners.
Is Wall Street Missing American Brivision's Full Clinical Safety and Efficacy Study? We Think it has.
Potential Partners are Now Able to Examine Vitargus® the...












